from adipocytes was observed after treatment with aspirin (p Ͻ 0.05).
In the present study, we showed for the first time the production of a major acute-phase protein, CRP, by adipocytes isolated from human adipose tissue in response to inflammatory cytokines, thereby suggesting a new link between obesity and vascular inflammation.
Adipose tissue secretes various bioactive substances, generally referred to as adipocytokines, including IL-6, TNF-alpha, leptin, adiponectin, and resistin, that may contribute to obesity-linked metabolic and vascular diseases (7) . In addition, obese individuals have high circulating levels of a range of inflammatory markers produced by adipose tissue, including IL-1-beta and IL-6 (8), cytokines responsible for both hepatic and extrahepatic production of CRP (4) . In several studies, high plasma levels of this acutephase protein were strongly associated with obesity and obesityrelated diseases (9) . There is recent evidence of CRP expression in human adipose tissue as well. Ouchi et al. (5) showed CRP mRNA expression in human adipose. However, they made no attempt to investigate the stimuli able to induce CRP. Here, we found that human adipocytes cultured in vitro produced CRP after exposure for 48 h to inflammatory cytokines, such as IL-1-beta, IL-6, and resistin. Interestingly, treatment of adipocytes with two other adipocytokines, adiponectin and leptin, did not lead to CRP production. Furthermore, treatment with several anti-inflammatory drugs shown to be effective in reducing serum CRP levels, such as aspirin, troglitazone, and fluvastatin (10,11), leads to reduction, but not complete inhibition, of CRP release from adipocytes. This might explain in part the beneficial cardiovascular effects of these drugs.
In conclusion, our study demonstrates that human adipocytes can produce CRP under the stimulation of several proinflammatory cytokines; moreover, CRP production may be modulated by selected pharmacologic intervention. The mechanism(s) underlying these findings are not fully defined, and further studies are needed in this area.
Letters to the Editor

Physiological Mechanisms of Atrially Induced Heart Rate Turbulence
We read with interest the study by Vikman et al. (1) and are pleased that this respectable group shares our interest in atrially induced heart rate turbulence. Although we understand the reasoning behind the suggestion that "vagal inhibition in response to premature atrial excitation is absent, or even that transient enhancement of vagal outflow occurs before atrial fibrillation," we would like to offer the investigators an alternative explanation for their findings.
We all would surely agree that less effective ventricular contraction and compensatory pause after premature beats is responsible for transient hemodynamic deficit, missed baroreflex afferent input, and early vagal inhibition. This mechanism is applicable for both ventricular and atrial premature complexes (APCs). Autonomic modulation of sinus nodal discharge after APCs may explain values of turbulence onset (TO) Յ0. When TO Ͼ0 is found, the underlying mechanism has to be different. The mechanism suggested by Vikman et al., namely the temporary direct suppression of sinus node automaticity, is certainly plausible. This phenomenon, which may mask (or overwhelm) the autonomic component of early acceleration, has been previously demonstrated (2) .
Because of a missing relationship between TO and APC prematurity, Vikman et al. rejected the hypothesis that sinus resetting is the predominant factor influencing the temporal changes of TO. However, this lack of correlation seems to us compatible rather than incompatible with sinus nodal resetting. Autonomically mediated TO should be positively related to the APC coupling interval, whereas TO mediated by direct suppression of sinus node automaticity should be negatively related to the APC coupling interval. Thus, coexistence of both mechanisms may effectively offset the relationship between TO and APC prematurity.
Although TO and turbulence slope after ventricular premature complexes and turbulence slope after APCs reflect heart rate vagal modulation, this is not the case for TO after APCs (3). We have not found any significant relationship between atrial TO and other previously established surrogates of heart rate vagal modulation in large Holter databases (Wichterle et al., unpublished data, 2005).
We thus wonder whether Vikman et al. (1) would agree that their finding might be interpreted as either 1) temporal decrease of vagal modulation, or 2) temporal change of APC prematurity (which cannot be exactly assessed from Holter recording) and/or site of origin of APCs-all factors potentially facilitating sinus node resetting. We believe that the latter possibility might be more probable because none of the other investigated indices of autonomic modulation (including 
